SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein
Artikelnummer:
PRS-21-823
| Artikelname: |
SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein |
| Artikelnummer: |
PRS-21-823 |
| Hersteller Artikelnummer: |
21-823 |
| Alternativnummer: |
PRS-21-823-0.025 |
| Hersteller: |
ProSci |
| Kategorie: |
Proteine/Peptide |
| Applikation: |
ELISA |
| Alternative Synonym: |
SARS-CoV-2 (COVID-19) Spike Recombinant Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Spike protein, Surface Glycoprotein, covid-19, sars-cov-2 |
| Konzentration: |
batch dependent |
| Molekulargewicht: |
1286 amino acids (including Rho1D4 tag and linker), 142115.37 Da |
| NCBI: |
43740568 |
| UniProt: |
P0DTC2 |
| Puffer: |
20 mM Hepes pH 7.5, 150 mM NaCl, 0.001 % LMNG |
| Quelle: |
HEK293 cells |
| Reinheit: |
>98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Rho1D4 Agarose. |
| Formulierung: |
Liquid |
| Anwendungsbeschreibung: |
This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only. |
